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Background
In pulmonary arterial hypertension (PAH), increased vas-
cular resistance causes functional and structural changes
in the right ventricle (RV), ultimately leading to right heart
failure and death. Predictors of patient survival include RV
cardiac index (RVCI) and pulmonary vascular resistance
(PVR). First-pass contrast bolus hemodynamics, such as
cardiopulmonary transit time (PTT), full-width-half-maxi-
mum (FWHM), and time-to-peak, have been associated
with left ventricular (LV) function; however, their relation
to RV function and pulmonary hemodynamics as well as
their significance in PAH have not been investigated.
Purpose
To evaluate first-pass contrast bolus hemodynamic para-
meters in relation to biventricular function and pulmon-
ary hemodynamics in patients undergoing right heart
catheterization (RHC) for known or suspected PAH.
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Figure 1 ROI Placement and Time-Intensity Curves. Short-axis saturation-recovery GRE image (A) demonstrates regions of interest placed in the
right (red) and left (green) ventricular cavities. Time-intensity curves (B) illustrate the passage of the contrast bolus through the regions of
interest and signify the calculated parameters; peak-to-peak cardiopulmonary transit time, full-width-half-maximum (FWHM), and time-to-peak
(TTP)
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43 patients (36 females, 58.7 years) underwent RHC and
3T cardiac MRI on the same day. 32 were confirmed to
have PAH (mPAP 40 [29-49] mmHg), 11 did not have
PAH (mPAP 17 [15-20] mmHg). 18 age- and gender-
matched healthy volunteers were included.
For evaluation of bolus hemodynamics, a 1:10 diluted
contrast bolus (0.0025ml/min/kg) of gadopentetate dime-
glumine was administered intravenously, and a short-axis
saturation-recovery GRE slice was acquired in the proxi-
mal third of both ventricles over 40 heartbeats with one
image per beat. For analysis, two regions of interest were
drawn in the right and left ventricular cavities, and time-
intensity curves were generated. From these curves, PTT,
FWHM, and time-to-peak were calculated (Figure 1).
Results
Right-to-left-ventricular PTT, LV FWHM, and LV time-
to-peak for PAH patients (8.2s, 8.2s, 4.8s) were signifi-
cantly longer than for non-PAH (6.5s, p=0.006; 5.0s,
p=0.01; 3.6s, p=0.01) and control subjects (6.4s,
p=0.0003; 5.2s, p=0.0004; 3.2s, p<0.0001) (Table 1).
There were significant correlations of all three para-
meters with pulmonary hemodynamics and biventricular
function and structure (Table 2). In linear regression ana-
lysis, including PVRI, ventricular mass index (VMI), and
CI as covariates, PTT was predicted by RVCI and VMI,
while FWHM and time-to-peak were predicted by PVRI.
In receiver operator characteristics (ROC) analysis for
transit time to distinguish between PAH patients with
and without right heart failure (RVCI <2.2L/min/m
2)t h e
area under the ROC curve was 0.82 with a sensitivity of
100% and specificity of 63.6% for a threshold of 8.1s.
Conclusions
While right-to-left-ventricular PTT in PAH patients is
mainly predicted by right ventricular cardiac function
and biventricular remodeling, time-to-peak and FWHM
are associated with pulmonary vascular resistance. Their
predictive value regarding patient prognosis warrants
further investigation.
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Table 1 Transit times and contrast bolus dispersion
PAH
(n=32)
Non-PAH
(n=11)
Controls
(n=18)
P
Peak Transit Time (s) 8.2
††‡‡
[6.9-9.9]
6.5
††
[5.6-7.0]
6.4
‡‡
[5.7-7.1]
0.0003*
FWHM LV (s) 8.2
††‡‡
[5.7-11.4]
5.0
††
[4.0-7.3]
5.2
‡‡
[4.1-6.1]
0.0006*
Time-to-Peak
LV (s)
4.8
††‡‡
[3.9-6.5]
3.6
††
[2.7-4.0]
3.2
‡‡
[2.8-3.8]
0.0001*
Peak-to-peak cardiopulmonary transit time, left ventricular full-width-half-
maximum (FWHM) and time-to-peak measurements were significantly longer
for PAH patients than for non-PAH patients and healthy controls. Mann-
Whitney U test was used to comparison of all three groups: *p<0.01.
Wilcoxon rank-sum text was used for individual group comparisons: PAH vs
non-PAH:
† p<0.05,
††p<0.01; PAH vs. controls:
‡p<0.05,
‡‡ p<0.01.
Table 2 Correlations of Transit Time and Dispersion
Coefficients with Biventricular Function and Pulmonary
Hemodynamics
Peak-to-Peak
Transit Time
LV FWHM LV Time-to-
Peak
rp rp rp
Age 0.23 0.13 0.08 0.64 0.04 0.80
6MWD -0.35 0.03* -0.23 0.16 -0.32 0.05*
RHC Parameters
Mean RAP 0.20 0.20 0.19 0.24 0.22 0.16
Mean PAP 0.55 0.0001* 0.50 0.0008* 0.47 0.002*
Systolic PAP 0.57 <0.0001* 0.50 0.0008* 0.45 0.003*
PCWP 0.24 0.13 0.06 0.70 0.21 0.18
PVRI 0.64 <0.0001* 0.56 0.0001* 0.54 0.0002*
RHC RV Cardiac Index -0/
48
0.001* -0.37 0.02* -0.43 0.004*
RHC RV Stroke Volume
Index
-0.55 0.0001* -0.54 0.0002* -0.52 0.0004*
LV Stroke Work Index -0.48 0.001* -0.48 0.002* -0.44 0.003*
RV Stroke Work Index 0.30 0.049* 0.23 0.16 0.21 0.19
Cardiac MRI
Parameters
LV ED Volume/BSA -0.42 0.006* -0.40 0.009* -0.29 0.06
LV ES Volume/BSA -0.23 0.14 -0.14 0.38 0.04 0.004*
LV Stroke Volume Index -0.47 0.001* -0.50 0.0009* -0.44 0.004*
LV Cardiac Index -0.58 <0.0001* -0.45 0.003* -0.38 0.01*
LV EF -0.16 0.32 -0.31 0.049* -0.40 0.008*
LV Mass/BSA -0.10 0.53 -0.29 0.07 -0.09 0.59
RV ED Volume/BSA 0.22 0.16 0.09 0.58 0.15 0.35
RV ES Volume/BSA 0.37 0.01* 0.30 0.05 0.33 0.03*
RV Stroke Volume Index -0.48 0.001* -0.52 0.0006* -0.46 0.002*
RV Cardiac Index -0.59 <0.0001* -0.45 0.003* -0.42 0.006*
RV EF -0.54 0.0002* -0.50 0.0008* -0.52 0.0004*
RV Mass/BSA 0.47 0.001* 0.31 0.045* 0.30 0.05
Total Biventricular Mass/
BSA
0.28 0.06 0.11 0.51 0.19 0.24
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